Blog
RSS FeedPosted by Michael Wonder on 28 Nov 2022
Kintara Therapeutics granted fast track designation from FDA for REM-001 for cutaneous metastatic breast cancer
28 November 2022 - Kintara Therapeutics today announced that the US FDA has granted fast track designation to Kintara's REM-001 ...
Posted by Michael Wonder on 21 Jan 2018
A tale of 2 friends with breast cancer; 1 has coverage for costly drug, the other forced to pay
20 January 2018 - Two women say their cases challenge commonly held belief that B.C. is the gold standard for cancer ...
Posted by Michael Wonder on 07 Jan 2018
Cost-effectiveness analysis of germ-line BRCA testing in women with breast cancer and cascade testing in family members of mutation carriers
4 January 2018 - This study evaluated the cost-effectiveness of BRCA testing in Australian women with breast cancer, and cascade ...
Posted by Michael Wonder on 01 Oct 2016
Breast cancer drug tamoxifen listed on Pharmaceutical Benefits Scheme
1 October 2016 - More Australian women will have access to a preventative breast cancer medicine that has been listed on ...
Posted by Michael Wonder on 09 May 2016
Updated treatment algorithm for the treatment of HER2+ metastatic breast cancer
1 May 2016 - The PBAC treatment algorithm for anti-HER2 therapies for treating metastatic breast cancer has been updated to reflect ...